Samsara BioCapital’s Amarin Corp AMRN Stock Holding History

Samsara BioCapital’s Portfolio AMRN Stock Details AMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,250	Closed	-$82K	–	58
2022 Q1	$82K	Hold	1,250	–	–	0.02%	57
2021 Q4	$84K	Hold	1,250	–	–	0.02%	51
2021 Q3	$128K	Hold	1,250	–	–	0.02%	48
2021 Q2	$110K	Hold	1,250	–	–	0.01%	50
2021 Q1	$155K	Hold	1,250	–	–	0.03%	44
2020 Q4	$122	Hold	1,250	–	–	0.01%	43
2020 Q3	$105K	Sell	1,250 -1,250	-50%	-$150K	0.03%	36
2020 Q2	$346K	Sell	2,500 -7,260	-74%	-$999K	0.11%	31
2020 Q1	$781K	Buy	+9,760	New	+$3.24M	0.45%	27

Other funds holding AMRN

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

DCM

DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Samsara BioCapital's AMRN Position: Q2 2022 in Review

Samsara BioCapital sold out of Amarin Corp (AMRN) in Q2 2022, closing a stake of 1,250 shares — an estimated $82K sold.

Samsara BioCapital first reported a position in AMRN in Q1 2020 and held it in 9 quarters. The position peaked at $781K in Q1 2020. 230 funds tracked by Wall St. Rank hold AMRN as of Q2 2022.

Samsara BioCapital reported no remaining Amarin Corp position as of Q2 2022 after selling out during the quarter.
Samsara BioCapital sold 1,250 Amarin Corp shares in Q2 2022, an estimated $82K.
Samsara BioCapital first reported a position in Amarin Corp in Q1 2020 and held it in 9 quarters.
Samsara BioCapital's Amarin Corp position peaked at $781K in Q1 2020.
230 funds tracked by Wall St. Rank held Amarin Corp as of Q2 2022.

Based on Samsara BioCapital's 13F filing for Q2 2022, filed 15 Aug 2022.